FAM114A2, a protein encoded by the FAM114A2 gene, can be activated through various cellular signaling pathways that are influenced by specific chemical compounds. One such mechanism involves the modulation of intracellular cyclic AMP (cAMP) levels. Compounds that activate adenylyl cyclase or inhibit phosphodiesterases result in elevated cAMP, which in turn could enhance the activity of FAM114A2 if it is regulated by cAMP-dependent signaling. This elevation of cAMP within cells can be achieved through different agents, some of which mimic the action of adrenergic agonists, increasing the production of this second messenger, whereas others prevent the degradation of cAMP, ensuring prolonged signaling and potential upregulation of FAM114A2 function. Additionally, certain compounds that increase intracellular calcium concentrations might also indirectly activate FAM114A2, presuming the protein is sensitive to calcium-mediated signaling pathways.
Furthermore, the activity of FAM114A2 is potentially influenced by agents that disrupt normal cellular processes, such as protein synthesis inhibition or the alteration of kinase activity. These disruptions can initiate stress responses or cell cycle alterations that may inadvertently lead to the activation of FAM114A2. For example, through the application of kinase inhibitors or protein synthesis disruptors, cells can trigger a cascade of stress-activated protein kinases, which could have downstream effects on FAM114A2 activity. In addition, the modulation of protein phosphatase activity has been shown to alter phosphorylation states within the cell, which could, in turn, influence the functional state of FAM114A2, thereby leading to its activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, elevating intracellular cAMP and possibly activating FAM114A2 by sustaining cAMP signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that stimulates adenylyl cyclase to raise cAMP levels, indirectly promoting FAM114A2 activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selective inhibitor of phosphodiesterase 4 (PDE4), increasing cAMP concentrations, potentially enhancing FAM114A2 activity via this second messenger. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 activates G-protein-coupled receptors that can increase cAMP, thereby potentially upregulating FAM114A2 function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that increases intracellular calcium levels, which may indirectly activate FAM114A2 if it is regulated by calcium signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that can activate cAMP-dependent pathways, possibly leading to the activation of FAM114A2. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Stimulates adenylyl cyclase via adrenergic receptors, increasing cAMP and potentially influencing FAM114A2 activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Phosphodiesterase 5 inhibitor, increasing cGMP levels, which might cross-activate cAMP pathways and subsequently FAM114A2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits protein synthesis and also activates stress-activated protein kinases, which may lead to the activation of FAM114A2 through stress response pathways. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Cyclin-dependent kinase inhibitor that may disrupt cell cycle control pathways, potentially leading to the activation of FAM114A2. | ||||||